Clinical Analysis Of Pancreatic Duct Stent Implantation In The Prevention Of Post-ERCP Pancreatitis After Endoscopic Retrograde Cholangiopancreatography

Ojective Discuss ERCP intraoperative into the effectiveness of the pancreatic duct stent to prevent post-ERCP pancreatitis,whether it can reduce the average patient post-ERCP pancreatitis and the incidence of Hyperamylasemia and PEP high-risk patients with acute pancreatitis and the incidence of Hyperamylasemia,thus for therapeutic ERCP provide reliable basis for the selection of the preventive measures of post-ERCP pancreatitis.Methods Through a retrospective analysis of the clinical data of patients diagnosised choledocholithiasis treated by the general hospital of ningxia medical university of(including general hospital and cardiovascular and cerebral vascular disease hospital)from April 2015 to April 2017,the incidence of pancreatitis and Hyperamylasemia in the patients with pancreatic duct stents and the patients who were not admitted to the pancreatic duct stents were analyzed in the statistical technique,and the effectiveness of the stent placement in the ERCP was discussed.Results Two groups of patients with preoperative and postoperative serum amylase value 24 h and 48 h comparison: two groups of patients with preoperative serum amylase value comparison difference has no statistical significance(P > 0.05).The pancreatic duct stent group 24 h and 48 h blood amylase value are lower than the control group,the difference was statistically significant(P < 0.05)Conclusions In ERCP,the insertion of pancreatic duct stents can improve thedrainage of pancreatic juice caused by mechanical stimulation,which can significantly reduce the incidence of acute pancreatitis and high amylase in patients at high risk.Therefore,the effective prevention of acute pancreatitis in high-risk patients after surgery is an effective way to prevent postoperative pancreatitis in patients with high risk of PEP.